Sessile serrated lesion

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Sessile serrated lesion
Sessile serrated lesion under microscope
Synonyms	Sessile serrated adenoma, sessile serrated polyp
Pronounce	N/A
Specialty	N/A
Symptoms	Often asymptomatic; may include rectal bleeding, anemia, or changes in bowel habits
Complications	Potential progression to colorectal cancer
Onset	Typically in adults over 50 years old
Duration	Chronic
Types	N/A
Causes	Unknown; associated with genetic mutations such as BRAF mutation
Risks	Family history of colorectal cancer, smoking, obesity
Diagnosis	Colonoscopy with biopsy
Differential diagnosis	Hyperplastic polyp, traditional serrated adenoma, tubular adenoma
Prevention	Regular screening colonoscopies, healthy lifestyle
Treatment	Endoscopic removal, polypectomy
Medication	N/A
Prognosis	Good if detected and removed early
Frequency	Common, especially in older adults
Deaths	N/A

Sessile serrated lesion

Sessile serrated lesion

Sessile serrated lesion

Sessile Serrated Lesion (SSL) is a type of colorectal polyp that is considered a precursor to colorectal cancer, specifically through the serrated pathway. SSLs are characterized by their sessile (flat) appearance and serrated (saw-tooth) pattern of the epithelial crypts. These lesions are significant in the context of colorectal cancer screening and prevention due to their potential for malignant transformation.

Epidemiology

Sessile serrated lesions are more commonly found in the right colon and are believed to account for up to 20% of sporadic colorectal cancers. The prevalence of SSLs increases with age, and they are more commonly identified in women than in men.

Pathophysiology

The pathogenesis of sessile serrated lesions involves genetic and epigenetic changes, including mutations in the BRAF gene and hypermethylation of CpG islands leading to MLH1 silencing. These molecular alterations disrupt normal cell apoptosis and promote unchecked cell proliferation, setting the stage for the development of dysplasia and, eventually, carcinoma.

Clinical Features

SSLs are often asymptomatic and are usually discovered incidentally during colonoscopy. Due to their flat morphology and subtle endoscopic features, they can be challenging to detect and adequately remove.

Diagnosis

The diagnosis of a sessile serrated lesion is primarily made through histological examination of polyp tissue obtained during colonoscopy. Endoscopically, SSLs may appear as slightly elevated, mucus-covered lesions that are difficult to distinguish from the surrounding mucosa. Advanced imaging techniques, such as narrow-band imaging (NBI), can aid in the detection of these lesions.

Management

The management of sessile serrated lesions involves endoscopic removal, typically through polypectomy or endoscopic mucosal resection (EMR). Given the risk of progression to colorectal cancer, it is crucial to ensure complete removal of the lesion. Follow-up surveillance colonoscopy is recommended due to the risk of recurrence and the development of new lesions.

Prevention

Preventive measures for sessile serrated lesions and colorectal cancer include regular screening colonoscopy, lifestyle modifications such as a healthy diet and regular exercise, and possibly the use of aspirin in specific high-risk individuals.

Summary

Sessile serrated lesions represent a critical target in the prevention of colorectal cancer. Early detection and removal of these lesions can significantly reduce the risk of progression to cancer. Ongoing research into the molecular pathways involved in the development of SSLs may provide new strategies for prevention and treatment.